We are thrilled to announce our partnership with QDX, pioneers in revolutionizing molecular research through advanced computational technologies. Together, we're integrating Chemspace's extensive virtual compound library directly into QDX's state-of-the-art Rush platform, creating a streamlined environment for preclinical drug design.
What does this mean for researchers?
Rush's AI, named Walter, is now deeply integrated with advanced computational tools and Chemspace's virtual compounds. This enables Walter to eliminate friction and empower scientists to make smarter, faster decisions - accelerating drug discovery and innovation.
We are rethinking how non-computational scientists interact with computational tools, making drug discovery faster, smarter, and more accessible than ever.
QDX is a drug discovery company specializing in high-performance quantum simulations that accelerate the design of new therapeutics. Its flagship platform, Rush, unlocks computational chemistry for non-computational scientists — enabling faster iteration and more impactful discoveries by putting powerful tools in the hands of domain experts.
